File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1002/pros.23380
- Scopus: eid_2-s2.0-85021447444
- PMID: 28656603
- WOS: WOS:000405732100005
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS)
Title | A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) |
---|---|
Authors | |
Keywords | BPH genome-wide association study LUTS |
Issue Date | 2017 |
Citation | Prostate, 2017, v. 77, n. 11, p. 1213-1220 How to Cite? |
Abstract | Background: Benign prostatic hyperplasia (BPH) and associated lower urinary tract symptoms (LUTS) are common conditions. Little is known about their etiologies except that studies have suggested a substantial heritable component. Our objective is to provide a comprehensive, genome-wide evaluation of inherited risks and possible mechanisms of etiology in BPH. Methods: We performed a three-stage, genome-wide association study (GWAS) of men from three independent populations, the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial, the CLUE II cohort, and a Finnish hospital-based population. DNA samples were genotyped using the Illumina HumanOmniExpress BeadChip in REDUCE and CLUE II, and using the Sequenom iPLEX system for the confirmation stage in the Finnish population. A logistic regression model was used to evaluate the association between each SNP and BPH/LUTS. Results: Fourteen SNPs reached P < 5.0 × 10−4 in the meta-analysis of the two GWASs (CLUE II and REDUCE). A total of 773 SNPs were chosen for the confirmation step in the Finish cohort. Only one SNP (rs17144046) located ∼489 kb downstream of GATA3 remained significant after correction for multiple testing (P < 6.5 × 10−5). This SNP marginally reached the GWAS significance level after performing a meta-analysis of the three stages (P-meta = 8.89 × 10−7). Expression quantitative trait loci (eQTL) analyses showed that the risk allele (G) of rs17144046 was significantly associated with increased expression of GATA3 (P = 0.017). Reported studies indicated a close correlation between GATA3 and BPH pathogenesis and progression. Conclusions: Rs17144046 located near GATA3 was significantly associated with BPH/LUTS in three independent populations, but did not reach a stringent GWAS significance level. Genetic variants of GATA3 may play a role in the inherited susceptibility and etiology of BPH/LUTS. Further research in this area is needed. |
Persistent Identifier | http://hdl.handle.net/10722/314397 |
ISSN | 2023 Impact Factor: 2.6 2023 SCImago Journal Rankings: 1.032 |
PubMed Central ID | |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Na, Rong | - |
dc.contributor.author | Helfand, Brian T. | - |
dc.contributor.author | Chen, Haitao | - |
dc.contributor.author | Conran, Carly A. | - |
dc.contributor.author | Crawford, Susan E. | - |
dc.contributor.author | Hayward, Simon W. | - |
dc.contributor.author | Tammela, Teuvo L.J. | - |
dc.contributor.author | Hoffman-Bolton, Judy | - |
dc.contributor.author | Zheng, Siqun L. | - |
dc.contributor.author | Walsh, Patrick C. | - |
dc.contributor.author | Schleutker, Johanna | - |
dc.contributor.author | Platz, Elizabeth A. | - |
dc.contributor.author | Isaacs, William B. | - |
dc.contributor.author | Xu, Jianfeng | - |
dc.date.accessioned | 2022-07-20T12:03:56Z | - |
dc.date.available | 2022-07-20T12:03:56Z | - |
dc.date.issued | 2017 | - |
dc.identifier.citation | Prostate, 2017, v. 77, n. 11, p. 1213-1220 | - |
dc.identifier.issn | 0270-4137 | - |
dc.identifier.uri | http://hdl.handle.net/10722/314397 | - |
dc.description.abstract | Background: Benign prostatic hyperplasia (BPH) and associated lower urinary tract symptoms (LUTS) are common conditions. Little is known about their etiologies except that studies have suggested a substantial heritable component. Our objective is to provide a comprehensive, genome-wide evaluation of inherited risks and possible mechanisms of etiology in BPH. Methods: We performed a three-stage, genome-wide association study (GWAS) of men from three independent populations, the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial, the CLUE II cohort, and a Finnish hospital-based population. DNA samples were genotyped using the Illumina HumanOmniExpress BeadChip in REDUCE and CLUE II, and using the Sequenom iPLEX system for the confirmation stage in the Finnish population. A logistic regression model was used to evaluate the association between each SNP and BPH/LUTS. Results: Fourteen SNPs reached P < 5.0 × 10−4 in the meta-analysis of the two GWASs (CLUE II and REDUCE). A total of 773 SNPs were chosen for the confirmation step in the Finish cohort. Only one SNP (rs17144046) located ∼489 kb downstream of GATA3 remained significant after correction for multiple testing (P < 6.5 × 10−5). This SNP marginally reached the GWAS significance level after performing a meta-analysis of the three stages (P-meta = 8.89 × 10−7). Expression quantitative trait loci (eQTL) analyses showed that the risk allele (G) of rs17144046 was significantly associated with increased expression of GATA3 (P = 0.017). Reported studies indicated a close correlation between GATA3 and BPH pathogenesis and progression. Conclusions: Rs17144046 located near GATA3 was significantly associated with BPH/LUTS in three independent populations, but did not reach a stringent GWAS significance level. Genetic variants of GATA3 may play a role in the inherited susceptibility and etiology of BPH/LUTS. Further research in this area is needed. | - |
dc.language | eng | - |
dc.relation.ispartof | Prostate | - |
dc.subject | BPH | - |
dc.subject | genome-wide association study | - |
dc.subject | LUTS | - |
dc.title | A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) | - |
dc.type | Article | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1002/pros.23380 | - |
dc.identifier.pmid | 28656603 | - |
dc.identifier.pmcid | PMC5565164 | - |
dc.identifier.scopus | eid_2-s2.0-85021447444 | - |
dc.identifier.volume | 77 | - |
dc.identifier.issue | 11 | - |
dc.identifier.spage | 1213 | - |
dc.identifier.epage | 1220 | - |
dc.identifier.eissn | 1097-0045 | - |
dc.identifier.isi | WOS:000405732100005 | - |